казалось бы, дорого. но
Mr. Caruso [the chief commercial officer for Allos] also said the price of Folotyn was not out of line with that of other drugs for rare cancers. Patients, moreover, are likely to use the drug for only a couple of months because the tumor worsens so quickly, he said. So the total cost of using Folotyn will be less than for many other drugs with lower monthly prices.
жить будете плохо, зато недолго